TY - JOUR
T1 - 3TR
T2 - a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD
AU - Porsbjerg, Celeste
AU - Maitland-van der Zee, Anke H
AU - Brusselle, Guy
AU - Canonica, Giorgio Walter
AU - Agusti, Alvar
AU - Faner, Rosa
AU - Vogelmeier, Claus F
AU - Nawijn, Martijn
AU - van den Berge, Maarten
AU - Rusconi, Franca
AU - Pilette, Charles
AU - Ramiconi, Valeria
AU - Coleman, Courtney
AU - Chaudhuri, Rekha
AU - Chung, Kian Fan
AU - Wedzicha, Jadwiga
AU - Saglani, Sejla
AU - Van der Schee, Marc P
AU - Heaney, Liam
AU - Bourdin, Arnaud
AU - Roberts, Graham
AU - Djukanovic, Ratko
AU - Kuna, Piotr
AU - Kupczyk, Maceij
AU - Axmann, Judith
AU - Staudinger, Heribert
AU - Clarke, Graham W
AU - Dahlen, Sven Erik
AU - Brightling, Chris
PY - 2021/10
Y1 - 2021/10
N2 - 3TR, the largest IMI consortium ever in immune diseases, brings clinical researchers and scientists from several disease areas together, in an endeavour to increase the clinical impact of targeted immune-mediated therapies, including asthma and COPD.
AB - 3TR, the largest IMI consortium ever in immune diseases, brings clinical researchers and scientists from several disease areas together, in an endeavour to increase the clinical impact of targeted immune-mediated therapies, including asthma and COPD.
KW - Asthma/drug therapy
KW - Cross-Sectional Studies
KW - Humans
KW - Pulmonary Disease, Chronic Obstructive/drug therapy
U2 - 10.1183/13993003.02168-2021
DO - 10.1183/13993003.02168-2021
M3 - Editorial
C2 - 34675035
SN - 0903-1936
VL - 58
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 4
M1 - 2102168
ER -